glp 1 agonist anti inflammatory GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease A large review of almost
Description
HusainMBirkenfeldALDonsmarkMDunganKEliaschewitzFGFrancoDRet alOral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
For self-funded employers, this reinforces a critical point: this isnt a one-time strategy decisionits a moving target
doi: 10.3389/fendo.2018.00233 71 EverardABelzerCGeurtsLOuwerkerkJPDruartCBindelsLBet al
These findings open new possibilities for treating conditions beyond weight and blood sugar management
Life sciences
